Skyline Therapeutics – A fully-integrated gene therapy company.
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting, Business News - AsiaOne
Oligonucleotide & Peptide Therapeutics (TIDES) 2022 - CPC Scientific
GTCR Seeks $1 Billion to Extend Ownership of TerSera Therapeutics - WSJ
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases - Dec 16, 2021
Find Therapeutics launches in Montreal – Find Therapeutics
About - Pheno Therapeutics
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
True North Therapeutics raises $45M in Series D toward rare drug trials | Fierce Biotech
JW Therapeutics, a China CAR-T biotech formed by Juno and WuXi, gains $90M series A | Fierce Biotech
SNMMI Therapeutics Conference - Tema Sinergie
Ovid Therapeutics - In-house Legal Case Study | LawVu
Spark Therapeutics to Invest $575M in New State-of-the-Art Gene Therapy Innovation Center on Drexel's University City Campus
Pittsburgh Inno - NeuBase Therapeutics halting further development operations to pursue business alternatives
Rinri Therapeutics Is Developing a Stem Cell Therapy for Deafness
BlueRock Therapeutics Wins $1M from NY State for R&D Hub, Launches MSK Neuro Collaboration
Atriva Therapeutics on X: "A huge thank you for interesting discussions at #BioEquity in Milan! “Round two” - digital #partnering - is right around the corner. If you haven't had the chance
Skyline Therapeutics Receives FDA Clearance of IND for Novel Gene Therapy Candidate for Macular Degeneration | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
تويتر \ BIOVECTRA (BioVectra@)
Skyline Therapeutics (Shanghai) Co. Ltd. | BioWorld
Articles about Precision Therapeutics (Formerly Known as Skyline Medical)
CNS Therapeutics XChange 2023 East Coast and Essential Tremor Congress | SynapCell
FDA approves Skyline Therapeutics' IND for macular degeneration trial - Pharmaceutical Technology
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases - Dec 16, 2021
FDA approves Skyline Therapeutics' IND for macular degeneration trial - Pharmaceutical Technology
